Goldman Sachs’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.17M | Sell |
4,749,876
-822,026
| -15% | -$1.41M | ﹤0.01% | 2415 |
|
|
2025
Q1 | $18.6M | Buy |
5,571,902
+1,461,846
| +36% | +$4.87M | ﹤0.01% | 1766 |
|
|
2024
Q4 | $30.4M | Sell |
4,110,056
-279,976
| -6% | -$2.07M | ﹤0.01% | 1446 |
|
|
2024
Q3 | $41.2M | Buy |
4,390,032
+1,768,248
| +67% | +$16.6M | 0.01% | 1194 |
|
|
2024
Q2 | $21M | Sell |
2,621,784
-1,160,779
| -31% | -$9.31M | ﹤0.01% | 1568 |
|
|
2024
Q1 | $56.1M | Buy |
3,782,563
+101,003
| +3% | +$1.5M | 0.01% | 924 |
|
|
2023
Q4 | $29.9M | Sell |
3,681,560
-82,078
| -2% | -$667K | 0.01% | 1285 |
|
|
2023
Q3 | $17.1M | Buy |
3,763,638
+228,371
| +6% | +$1.04M | ﹤0.01% | 1622 |
|
|
2023
Q2 | $24.9M | Sell |
3,535,267
-397,717
| -10% | -$2.8M | 0.01% | 1395 |
|
|
2023
Q1 | $24M | Buy |
3,932,984
+289,919
| +8% | +$1.77M | 0.01% | 1388 |
|
|
2022
Q4 | $23.3M | Buy |
3,643,065
+648,086
| +22% | +$4.14M | 0.01% | 1485 |
|
|
2022
Q3 | $28.7M | Buy |
2,994,979
+1,042,633
| +53% | +$9.99M | 0.01% | 1323 |
|
|
2022
Q2 | $21.6M | Buy |
1,952,346
+1,377,975
| +240% | +$15.2M | 0.01% | 1566 |
|
|
2022
Q1 | $9.56M | Sell |
574,371
-875,433
| -60% | -$14.6M | ﹤0.01% | 2278 |
|
|
2021
Q4 | $27.7M | Buy |
1,449,804
+194,704
| +16% | +$3.72M | 0.01% | 1532 |
|
|
2021
Q3 | $31M | Sell |
1,255,100
-387,478
| -24% | -$9.56M | 0.01% | 1405 |
|
|
2021
Q2 | $42.7M | Sell |
1,642,578
-274,931
| -14% | -$7.15M | 0.01% | 1191 |
|
|
2021
Q1 | $60.7M | Buy |
1,917,509
+1,171,739
| +157% | +$37.1M | 0.02% | 896 |
|
|
2020
Q4 | $34.6M | Sell |
745,770
-73,381
| -9% | -$3.4M | 0.01% | 1202 |
|
|
2020
Q3 | $27M | Sell |
819,151
-612,174
| -43% | -$20.2M | 0.01% | 1281 |
|
|
2020
Q2 | $39.3M | Buy |
1,431,325
+362,717
| +34% | +$9.96M | 0.01% | 1028 |
|
|
2020
Q1 | $32M | Sell |
1,068,608
-132,246
| -11% | -$3.96M | 0.01% | 1059 |
|
|
2019
Q4 | $33.2M | Buy |
1,200,854
+153,062
| +15% | +$4.24M | 0.01% | 1278 |
|
|
2019
Q3 | $19.1M | Buy |
1,047,792
+474,414
| +83% | +$8.63M | 0.01% | 1553 |
|
|
2019
Q2 | $14.1M | Buy |
573,378
+136,115
| +31% | +$3.34M | ﹤0.01% | 1785 |
|
|
2019
Q1 | $4.16M | Sell |
437,263
-256,038
| -37% | -$2.43M | ﹤0.01% | 2549 |
|
|
2018
Q4 | $6.14M | Buy |
693,301
+500,765
| +260% | +$4.43M | ﹤0.01% | 2187 |
|
|
2018
Q3 | $2.17M | Buy |
192,536
+107,499
| +126% | +$1.21M | ﹤0.01% | 2838 |
|
|
2018
Q2 | $1.09M | Sell |
85,037
-9,756
| -10% | -$125K | ﹤0.01% | 3157 |
|
|
2018
Q1 | $1.6M | Buy |
94,793
+39,179
| +70% | +$662K | ﹤0.01% | 2977 |
|
|
2017
Q4 | $445K | Sell |
55,614
-153,670
| -73% | -$1.23M | ﹤0.01% | 3509 |
|
|
2017
Q3 | $1.62M | Sell |
209,284
-4,027
| -2% | -$31.2K | ﹤0.01% | 2976 |
|
|
2017
Q2 | $1.57M | Sell |
213,311
-41,146
| -16% | -$302K | ﹤0.01% | 2922 |
|
|
2017
Q1 | $1.9M | Buy |
254,457
+198,051
| +351% | +$1.48M | ﹤0.01% | 2767 |
|
|
2016
Q4 | $392K | Sell |
56,406
-12,144
| -18% | -$84.4K | ﹤0.01% | 3586 |
|
|
2016
Q3 | $564K | Sell |
68,550
-210,801
| -75% | -$1.73M | ﹤0.01% | 3377 |
|
|
2016
Q2 | $2.26M | Buy |
279,351
+228,287
| +447% | +$1.85M | ﹤0.01% | 2543 |
|
|
2016
Q1 | $259K | Buy |
51,064
+29,820
| +140% | +$151K | ﹤0.01% | 3623 |
|
|
2015
Q4 | $164K | Buy |
21,244
+5,268
| +33% | +$40.7K | ﹤0.01% | 3816 |
|
|
2015
Q3 | $92K | Buy |
+15,976
| New | +$92K | ﹤0.01% | 4196 |
|
|
2015
Q2 | – | Sell |
-35,131
| Closed | -$425K | – | 4667 |
|
|
2015
Q1 | $425K | Buy |
+35,131
| New | +$425K | ﹤0.01% | 3419 |
|